Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

National Research (NRC)

  • Business News
  • Jan. 28, 2026, 15:31 UTC
  • 0
  • 1 comments

Your essential CAHPS update in just 30 minutes | CAHPS Insider Live

Market reaction Comment Full text

Healthcare Triangle Inc (HCTI)

  • Business News
  • Jan. 28, 2026, 15:10 UTC
  • 1
  • 1 comments

Healthcare Triangle, Inc. Announces Participation and Presentation at the Deal Flow Discovery Conference in Atlantic City

Market reaction Comment Full text

Air Products and Chemicals Inc (APD)

  • Business News
  • Jan. 28, 2026, 15:05 UTC
  • 1
  • 1 comments

Air Products Wins More than $140 Million in NASA Contracts to Supply Liquid Hydrogen to the Kennedy Space Center, Cape Canaveral Space Force Station and Other NASA Facilities

Market reaction Comment Full text

Repare Therapeutics Inc (RPTX)

  • SEC News
  • Jan. 28, 2026, 14:48 UTC
  • 1
  • 0 comments

New Form 25-NSE - Repare Therapeutics Inc. <b>Filed:</b> 2026-01-28 <b>AccNo:</b> 0001354457-26-000100 <b>Size:</b> 3 KB

Comment Full text

VistaGen Therapeutics Inc. (VTGN)

  • Business News
  • Jan. 28, 2026, 14:00 UTC
  • 1
  • 1 comments

LEVI & KORSINSKY, LLP NOTIFIES INVESTORS OF CLASS ACTION LAWSUIT AGAINST VISTAGEN THERAPEUTICS ALLEGING SECURITIES FRAUD IN DRUG DEVELOPMENT DISCLOSURES

Market reaction Comment Full text

agilon health Inc (AGL)

  • Business News
  • Jan. 28, 2026, 14:00 UTC
  • 1
  • 1 comments

Investors in agilon health, inc. Should Contact Levi & Korsinsky Before March 2, 2026 to Discuss Your Rights - AGL

Market reaction Comment Full text

Immix Biopharma Inc (IMMX)

  • Business News
  • Jan. 28, 2026, 13:45 UTC
  • 1
  • 1 comments

Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201

Market reaction Comment Full text

GRI Bio Inc (GRI)

  • Business News
  • Jan. 28, 2026, 13:45 UTC
  • 0
  • 1 comments

GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF

Market reaction Comment Full text

Tivic Health Systems Inc. (TIVC)

  • Business News
  • Jan. 28, 2026, 13:32 UTC
  • 0
  • 1 comments

Tivic, BARDA Discuss Entolimod™ for Acute Radiation Syndrome at TechWatch Meeting

Market reaction Comment Full text

Tenon Medical Inc (TNON)

  • Business News
  • Jan. 28, 2026, 13:32 UTC
  • 0
  • 1 comments

Tenon® Medical Issues Shareholder Letter and Provides Preliminary Revenue for the Fourth Quarter and Full Year 2025

Market reaction Comment Full text

Intelligent Bio Solutions Inc (INBS)

  • Business News
  • Jan. 28, 2026, 13:30 UTC
  • 0
  • 1 comments

Intelligent Bio Solutions Inc. - Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market

Market reaction Comment Full text

Icecure Medical Ltd (ICCM)

  • Business News
  • Jan. 28, 2026, 13:30 UTC
  • 0
  • 1 comments

IceCure Celebrates American Society of Breast Surgeons (ASBrS) Proposed Breast Cancer Treatment Guidelines Which Include Cryoablation for Low-Risk Breast Cancer

Market reaction Comment Full text

RenovoRx Inc. (RNXT)

  • Business News
  • Jan. 28, 2026, 13:30 UTC
  • 0
  • 1 comments

RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Oncology Annual Scientific Meeting

Market reaction Comment Full text

Dominari Holdings Inc (DOMH)

  • Business News
  • Jan. 28, 2026, 13:30 UTC
  • 0
  • 1 comments

Dominari Holdings Issues Letter to Shareholders

Market reaction Comment Full text

Quoin Pharmaceuticals Ltd DRC (QNRX)

  • SEC News
  • Jan. 28, 2026, 13:06 UTC
  • 1
  • 0 comments

New Form SCHEDULE 13G - Quoin Pharmaceuticals, Ltd. <b>Filed:</b> 2026-01-28 <b>AccNo:</b> 0001716774-26-000006 <b>Size:</b> 8 KB

Comment Full text
  • Previous
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next

Search

News categories

  • Technical Exchange News(10847)
  • Event(2223)
  • SEC News(187893)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124366)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin